chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician refers to a 3 years old female patient with none drug reactions/allergies. The patient was vaccinated with a dose of VARIVAX (Merck) (Lot number, dose and route not reported) in 2010. Concomitant medications included unspecified chemotherapy, induction therapy and blood transfusions. Physician reported that on 19-AUG-2012, 10 days ago, the patient was diagnosed with neuroblastoma. Physician noted that the patient had serologic testing on 23-AUG-2012 which revealed positive IgM and IgG levels for varicella, and patient had developed a fever and rash around her hair line and ear. Physician believed that this could be possible start of outbreak of varicella-zoster virus. On an unspecified date the patient was hospitalized. Computed tomography (CT) and other unspecified diagnostic tests were performed (results not provided). There was no treatment given for the events. At the time of the report, the patient had not recovered. The relatedness for neuroblastoma, possible start of outbreak of varicella-zoster virus, rash around her hair line and ear, fever and positive IgM and IgG levels for varicella was unknown for VARIVAX (Merck). Neuroblastoma, possible start of outbreak of varicella-zoster virus, rash around her hair line and ear, fever and positive IgM and IgG levels for varicella were considered disabling and life threatening by the reporter. Additional information has been requested.
Severe joint pain, tightness, cramping pain in neck and shoulder, lower back and shooting pain in legs pain, knee pain, unable to walk at times (worse says unable to walk 4/2 to 4/4)  blinding headache, sensitive to light, nausea worse after eating,   shortness of breath - unable to take walks outside. symptoms we're constant 4/2 to 4/7 and began coming and going 4/8.  Symptoms are becoming less difficult and less often. Still occurring daily, less often and not as severe
This spontaneous report received from a patient, concerned a patient of unspecified age and gender. Medical history, weight, height, concomitant medications and concurrent conditions not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin and batch number: not reported) dose: not reported, on Apr 12, 2021, for immunization. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient experienced somewhat of an adverse reaction. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome: not reported.
Patient received 2nd dose of Pfizer vaccine on Friday, had some headache and chills.  Saturday evening after dinner having chest pains (squeezing/pressure). Took tylenol which helped.  Was still there Sunday morning when he woke up.  Went to student health center on 04/19/21 with mild chest pains. Was diagnosed with acute pericarditis. Was referred to Cardiology the same day who did an Echo (no effusion) and put on Colchicine and NSAIDS for 1 month and was sent to recover at home.
pt exp fever, chills, sweats for muscle?;joint pain;T99.2-99.8;pale, dazed, dec consciousness, slow to respond, moody, confused, angry;h/a, pain dry cough, diff swallowing, sore throat;rash;dazed feeling;
Patient received the Moderna COVID-19 vaccine instead of the Pfizer COVID-19 vaccine based on his age
This case was reported by a consumer via call center representative and described the occurrence of pruritus in a female patient who received Shingrix for prophylaxis. On 10th September 2018, the patient received the 2nd dose of Shingrix. On 11th September 2018, 1 days after receiving Shingrix, the patient experienced pruritus. On an unknown date, the outcome of the pruritus was unknown. It was unknown if the reporter considered the pruritus to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient received a dose of Shingrix on an unknown arm. The patient reported itching on her chest.
hard red rash on left arm. lethargy, body aches, headache, sensitivity to light.
SIRVA? Pain in both arms, sometimes in my bicep  muscles  and other times in my shoulders. It moves from one area to the other.  Sometimes it impacts my ability to concentrate (because it's all I can focus on) or my movement  (reaching for things) and other times not. It's not excruciating but enough for me to take Tylenol or Back and Body pills for the pain to go away.
However she had Covid-19 and was in quarantine until 14Apr2021.; However she had Covid-19 and was in quarantine until 14Apr2021.; This is a spontaneous report from a Pfizer sponsored program by a contactable consumer (patient).  A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 15Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The consumer received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 15Mar2021, she was scheduled to receive the second dose of the vaccine on 05Apr2021, however she had Covid-19 and was in quarantine until 14Apr2021. The patient underwent lab tests and procedures which included COVID-19: positive she had Covid-19 on 2021.    Information on the lot/batch number has been requested.
Headaches, cold chills, fever, vomiting, loss of appetite, got a cold and passed it to spouse and son, body aches, metallic taste in mouth, hurts to take a deep breath, extreme tiredness
RAT tender to touch. No enduration. Topical redness at inject site. RAT warm to touch. Child doesn't have symptomatic fever. 48 hrs post injection, symptoms noted.
Hypokalemia Hypoxia Fever Pneumonia due to COVID-19 virus COVID-19
Swollen face/redness/numb lips coughing/tongue swelling trouble breathing.
extreme dizziness; trouble using her legs; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extreme dizziness), PAIN IN EXTREMITY (sore arm) and MUSCULOSKELETAL DISORDER (trouble using her legs) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history was reported.     On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 02-Apr-2021, the patient experienced DIZZINESS (extreme dizziness) and MUSCULOSKELETAL DISORDER (trouble using her legs). At the time of the report, DIZZINESS (extreme dizziness), PAIN IN EXTREMITY (sore arm) and MUSCULOSKELETAL DISORDER (trouble using her legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include blood thinner. No treatment medications were provided.
Acute vertigo occurred one week after vaccination. The feeling of dizziness has not gone away yet after one week.
I started itching on the 12th. On the 13th, I noticed a swollen lymph node. The next day it was even more swollen. It was the size of an avocado seed, thick and very warm. Friday when I got home to shower, is when I noticed the rash on my thighs. I got scared because of the color of it. After I showered, I called the COVID hotline, which is where I work. I spoke to a NP and she told me to take Benadryl, but I only had Claritin. She told me to contact Urgent Care and I spoke with a NP on the 16th. I was told to continue with the Claritin. It sill didn't help and I was told to contact Occupational Health. I called them on the 18th and they expedited my case and I was contacted by Allergy Immunology on the 26th. I started taking Benadryl on the 18th as well. In addition to that, I still have a burning like sensation on my right though. It goes from burning, to itching and a sharp pain, but only on my right side. The right side was raised, while the left side was flat and the color is more like a deep cherry red, while the left was just red. The allergist ran some tests and determined that I'm not actually allergic to peaches, but couldn't determine my allergy to COVID or alcohol.
Information has been received from a physician, concerning a 66 year old male patient with a sulfonamide allergy, who on 12-NOV-2007 was vaccinated SQ with a dose, 0.5 ml, of pneumococcal 23v polysaccharide vaccine (lot # 658447/1132U). On 14-NOV-2007 the patient developed redness, warmth and a 5 cm area of induration at the injection site, and was seen in the office. Treatment included levofloxacine (LEVAQUIN), diphenhydramine (BENADRYL), and cold compresses. On 15-NOV-2007, the patient was reexamined and the symptoms had not improved, so clindamycin and methylprednisolone (MEDROL DOSE PAK) were added as therapy. The following day, 16-NOV-2007, the symptoms had improved significantly, and the patient subsequently fully recovered (date not specified). This is one of three cases from the same reporter. Additional information has been requested.
pt recvd vax 3JUN94 & 15JUN94 pt devel macular rash over entire body, swollen lymph nodes behind neck & an elevated temp; presented to MD tx DPH;
I felt tired for 24 hours, but my worst symptom has been arm pain of the injection arm (beginning around 10 hours after injection and becoming the worst 48 hours after injection).  I cannot raise my arm more over shoulder height without pain.  My armpit is quite swollen and tender - I cannot tell if it is swelling of lymph nodes because I don't feel the nodules--it just feels puffy and swollen (it is also appears swollen).  The injection site is tender to the touch. I have occasional ulnar nerve pain in this arm, and the injection exacerbated it.
arm hurts; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurts). At the time of the report, PAIN IN EXTREMITY (arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       it was reported that patient has artritus
In vaccine clinic, 10-15 min after vaccine administration, c/o throat tingling. Given waters with vitals taken. given diphenhydramine 50 mg PO. Transferred to ED for throat swelling minutes after received Moderna Covid Vaccine.  Reports hoarse voice and difficulty breathing. No rash, hives, diarrhea, abdominal pain or dizziness. BP 138/80 HR 110, RR 18 SpO2 96%, EpiPen, methylprednisolone, and famotidine given.  No improvement within 15 minutes, so second EpiPen administered with gradual improvement in symptoms. Gradually developed chest pain approx 1.5 hours after 2nd dose Epi. Troponin ordered and EKG in setting of unchanged tachycardia HR 108-no acute ischemia. Kept overnight for observation. Discharged with shor t course prednisone and famotidine and advised to avoid 2nd vaccination. Re-presented to ED 48 hours later with c/o chest tightness that never completed resolved and increased SOB despite taking the prednisone and famotidine. Noted to have maculopapular rash on anterior chest. Treated with methylpred, around the clock diphenhydramine and famotidine. Discharged with albuterol MDI and medrol dosepak with instructions to stop prednisone, but continue famotidine. Referral to Allergy/Immunology pending.
I received my influenza vaccine on 10/25/2021 at facility. Several days after the shot, I noticed my pain was getting worse instead of improving in my right shoulder. I have been taking anti-inflammatory meds (ibuprofen), icing and stretching but it hasn't improved. The pain limits my range of motion and I have weakness in my arm now as well. The mornings are the worst with pain and limitations, I have a difficult time doing my hair because of the discomfort when my arm is in certain positions.
Chest pain, neurological, vision, bels palsey (heavy) fatigue, headaches migraines
Severe debiitaing migraine type headache with nausea and vomiting.  Continued for 3 days until treated.   Prescribed Methylprednisolone 4mg dosepak.  Headache and nausea resolved in 24 hours.  Intestinal recovery was 3 days.
left work early today as he just felt a little unsteady; dizzy; a lot of muscle aches; slight fever, 99.5, unusual for him; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him), HEADACHE (headache) and FATIGUE (left work early today as he just felt a little unsteady) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure, Diuretic effect, Blood sugar abnormal and COVID-19 in February 2021.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him) and HEADACHE (headache). On 15-Apr-2021, the patient experienced FATIGUE (left work early today as he just felt a little unsteady). At the time of the report, DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him), HEADACHE (headache) and FATIGUE (left work early today as he just felt a little unsteady) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 99.5 degree Celsius (High) 99.5 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The other relevant concomitant medication were reported as Blood Pressure medication, Diuretics and Blood sugar medications.  No treatment information was reported.
Hot at the injection site; Inflamed; Vaccination site rash; Noticed Redness; Itches a little bit; Swollen; A little sore; fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE INFLAMMATION (Inflamed), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Noticed Redness) and VACCINATION SITE PRURITUS (Itches a little bit) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and AMLODIPINE for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE INFLAMMATION (Inflamed), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Noticed Redness), VACCINATION SITE PRURITUS (Itches a little bit), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE PAIN (A little sore) and PYREXIA (fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE INFLAMMATION (Inflamed), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Noticed Redness), VACCINATION SITE PRURITUS (Itches a little bit), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE PAIN (A little sore) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: blood pressure BP done.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
NONE, tried calling parent but no answer, lmom for parent to return call 12/5/19 100pm
Patient first passed out at site of blood drop after vaccine administration then started seizing for 5-10 seconds. Patient then immediately awoken asking where he was. He was informed he was at pharmacy and was aware of the situation.
tired; pain in his arm; pain all over his body; a little fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in his arm), PAIN (pain all over his body), PYREXIA (a little fever) and FATIGUE (tired) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in his arm), PAIN (pain all over his body) and PYREXIA (a little fever). On 24-Mar-2021, the patient experienced FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (pain in his arm), PAIN (pain all over his body), PYREXIA (a little fever) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment 24Mar2021.
pt recvd vax & 15-60mins p/vax pt exp diff breathing, h/a, nausea;pt labored breathing responded to 2 doses of Epi;pt was taken to ER, was observed there, & then was released;
Brief but very severe vertigo with complete loss of eyesight. Followed by dizziness, weakness and nausea.
Administered by mistake a dose of Pediarix / Intended doses to be given / were Kinrix and Proquad; Pediarix and Ipol given concomitantly; This case was reported by a physician via call center representative and described the occurrence of wrong vaccine administered in a 4-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 47CX9, expiry date 29th May 2022) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and POLIOMYELITIS VACCINE (IPOL) for prophylaxis.   On 26th April 2021, the patient received the 4th dose of Pediarix, Pediarix Pre-Filled Syringe Device and IPOL. On 26th April 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and accidental overdose. The action taken with IPOL was unknown. On an unknown date, the outcome of the wrong vaccine administered and accidental overdose were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: Physician reported that the patient had been administered by mistake a dose of Pediarix as a 4th dose in the series of DTaP along with Ipol vaccine, intended doses to be given to the patient were Kinrix and Proquad, which led to wrong vaccine administered and accidental overdose. The reporter consented to follow up.
This case was reported by a pharmacist via call center representative and described the occurrence of cold sores in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced cold sores. On an unknown date, the outcome of the cold sores was unknown. It was unknown if the reporter considered the cold sores to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The healthcare professional did not have information about patient nor lot or expiry of vaccine available. After vaccination with SHINGRIX the patient experienced cold sores. The reporter did not consent to follow-up.
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. Since July 2014 the patients were vaccinated with a dose of improperly stored RECOMBIVAX HB (dose, route of administration and lot # were reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pain in the arm; Headache; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Pain in the arm), HEADACHE (Headache) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Pain in the arm), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, MYALGIA (Pain in the arm), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.
Pfizer Dose 1 2/19/21 (EN6200) Pfizer Dose 2 3/12/21 (EN6207) COVID Positive 4/29/21  5/3/21: A is a 6-year-old male past medical history significant for COPD with chronic bronchitis, AAA, pulmonary embolism chronic heart failure, OSA and previous smoker was referred from infusion center for hypoxia on room air of 88%.  Patient endorses that since field note Will with some shortness of breath; contacted PMD and COVID test was done and was found to be positive.  Patient was then referred to infusion center and was found to be hypoxic on room air 88% and referred to the emergency room. Patient endorses that progressively has been feeling short of breath with generalized malaise otherwise denies any fever chills or rigors. Patient had 2nd COVID-19 vaccine X2 doses in March. Patient was found to be hypoxic in the emergency room requiring 2 liter/minute to bring saturation to acceptable level. Chest x-ray shows mildly cardiomegaly with pulmonary vascular congestion and grossly scatter bilateral pleural plaques. CT angio of chest to rule out PE was done and was unremarkable for pulmonary embolism; however shows right lower lobe airspace disease that might represent pneumonia; intervals catheter bilateral calcified pleural plaques stable as prior.  5/11/21: Patient is an 86-year-old male was admitted with COVID-19 pneumonia with superimposed bacterial pneumonia. Patient had been vaccinated in March 2000 in 21 for COVID-19.  Patient was started on remdesivir received Actemra as well.  Patient was covered with IV Zosyn for possibility of superimposed bacterial pneumonia.  Blood cultures x2 were negative for the patient.  Pulmonology team was following the patient and we were able to successfully wean the patient down to room air. Pulmonology cleared the patient for discharge.  Patient was discharged to skilled nursing facility with a prednisone taper as recommended by pulmonology.  On 05/10/2021 patient had a sinus tachycardia and EKG revealed right bundle branch block which was discussed with Cardiology.  Patient was asymptomatic and Cardiology did not recommend any further workup for right bundle branch block.  Patient's electrolytes were in the normal range.  Patient was in sinus rhythm upon discharge from the hospital on 05/10/2021.  Patient was discharged to skilled nursing facility in a stable medical condition on 05/10/2021